CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Schering AG

For profitContributed to NME

Also known as: Berlex | Berlex Laboratories, Inc. | BERLEX LABS | Schering SA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Dec 27, 2005

Acquired by Bayer on Jan 1, 2009

Timeline

1850s

Jan 1, 1851
Schering AG— Founded

1990s

Jan 1, 1990
Jenapharm— Acquired
Mar 5, 1991
sargramostim— NDA Organization
Oct 22, 1999
Diatide— Acquired

2000s

Dec 27, 2005
norgestrel— Marketing Organization
Dec 27, 2005
norgestrel— NDA Secondary Org
Jan 1, 2009
Bayer— Acquired By

Drugs by trial phase (5 distinct, 3 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (2)

NCT00102661CollaboratorPhase 2Oct 1, 2002
NCT00925873CollaboratorPhase 3Jun 1, 1996

Details

Founded: Berlin, DE Jan 1, 1851
First NDA: Mar 5, 1991
Last known activity: Dec 27, 2005

Designations held

Orphan drug